ADNEXUS
DEAD

Serial Number

98680841

Owner

ADNEXUS BIOTECHNOLOGIES INC.

Attorney

Charles S. Cotropia

Filing Date

Aug 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ADNEXUS Trademark

Serial Number: 98680841

ADNEXUS is a trademark filed by ADNEXUS BIOTECHNOLOGIES INC. on August 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ADNEXUS BIOTECHNOLOGIES INC. (2 trademarks)

1756 Bison Meadow Lane
Heath, TX 75032

Entity Type: 03

Trademark Details

Filing Date

August 2, 2024

Registration Date

Not Registered

Published for Opposition

April 15, 2025

Goods & Services

Biotechnology products for human and animal use, namely, human and veterinary vaccines for the treatment and prevention of diseases; Pharmaceutical products for human use for the treatment and prevention of diseases in the nature of the human immunodeficiency virus (HIV) and COVID-19.

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 12, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 12, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 10, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 18, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2024 NWOS
NEW APPLICATION ENTERED
Aug 2, 2024 NWAP